203 related articles for article (PubMed ID: 23001705)
21. Parafibromin, APC, and MIB-1 Are Useful Markers for Distinguishing Parathyroid Carcinomas From Adenomas.
Hosny Mohammed K; Siddiqui MT; Willis BC; Zaharieva Tsvetkova D; Mohamed A; Patel S; Sharma J; Weber C; Cohen C
Appl Immunohistochem Mol Morphol; 2017; 25(10):731-735. PubMed ID: 27490759
[TBL] [Abstract][Full Text] [Related]
22. Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation.
Xu X; Ding H; Rao G; Arora S; Saclarides CP; Esparaz J; Gattuso P; Solorzano CC; Prinz RA
Endocr Relat Cancer; 2012 Apr; 19(2):167-79. PubMed ID: 22241722
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.
Erickson LA; Jin L; Wollan P; Thompson GB; van Heerden JA; Lloyd RV
Am J Surg Pathol; 1999 Mar; 23(3):288-95. PubMed ID: 10078919
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic significance of parafibromin expression in parathyroid carcinoma.
Gao Y; Wang P; Lu J; Pan B; Guo D; Zhang Z; Wang A; Zhang M; Sun J; Wang W; Liang Z
Hum Pathol; 2022 Sep; 127():28-38. PubMed ID: 35654240
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma.
Howell VM; Gill A; Clarkson A; Nelson AE; Dunne R; Delbridge LW; Robinson BG; Teh BT; Gimm O; Marsh DJ
J Clin Endocrinol Metab; 2009 Feb; 94(2):434-41. PubMed ID: 19017757
[TBL] [Abstract][Full Text] [Related]
26. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.
Cetani F; Marcocci C; Torregrossa L; Pardi E
Endocr Relat Cancer; 2019 Jul; 26(7):R441-R464. PubMed ID: 31085770
[TBL] [Abstract][Full Text] [Related]
27. The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors.
Vargas MP; Vargas HI; Kleiner DE; Merino MJ
Mod Pathol; 1997 Jan; 10(1):12-7. PubMed ID: 9021722
[TBL] [Abstract][Full Text] [Related]
28. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma.
Kim HK; Oh YL; Kim SH; Lee DY; Kang HC; Lee JI; Jang HW; Hur KY; Kim JH; Min YK; Chung JH; Kim SW
Head Neck; 2012 Feb; 34(2):201-6. PubMed ID: 21717519
[TBL] [Abstract][Full Text] [Related]
29. Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors.
Wang O; Wang CY; Shi J; Nie M; Xia WB; Li M; Jiang Y; Guan H; Meng XW; Xing XP
Chin Med J (Engl); 2012 Aug; 125(16):2895-901. PubMed ID: 22932087
[TBL] [Abstract][Full Text] [Related]
30. Quantitative proteomics analysis of sporadic parathyroid adenoma tissue samples.
Arya AK; Bhadada SK; Singh P; Dahiya D; Kaur G; Sharma S; Saikia UN; Behera A; Rao SD; Bhasin M
J Endocrinol Invest; 2019 May; 42(5):577-590. PubMed ID: 30284223
[TBL] [Abstract][Full Text] [Related]
31. Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue.
Hadar T; Shvero J; Yaniv E; Ram E; Shvili I; Koren R
Pathol Oncol Res; 2005; 11(1):45-9. PubMed ID: 15800682
[TBL] [Abstract][Full Text] [Related]
32. Determination-of apoptosis and cell cycle modulators (p16, p21, p27, p53, BCL-2, Bax, BCL-xL, and cyclin D1) in thyroid follicular carcinoma, follicular adenoma, and adenomatous nodules via a tissue microarray method.
Temiz P; Akkaş G; Neşe N; Uğur Duman F; Karakaş C; Erhan Y
Turk J Med Sci; 2015; 45(4):865-71. PubMed ID: 26422859
[TBL] [Abstract][Full Text] [Related]
33. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.
Cryns VL; Thor A; Xu HJ; Hu SX; Wierman ME; Vickery AL; Benedict WF; Arnold A
N Engl J Med; 1994 Mar; 330(11):757-61. PubMed ID: 7906387
[TBL] [Abstract][Full Text] [Related]
34. Aberrant expression of Sonic hedgehog signaling in Peutz-Jeghers syndrome.
Xu X; Su J; Li R; Wang Y; Zeng D; Wu B
Hum Pathol; 2016 Apr; 50():153-61. PubMed ID: 26997450
[TBL] [Abstract][Full Text] [Related]
35. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis.
Hoos A; Nissan A; Stojadinovic A; Shia J; Hedvat CV; Leung DH; Paty PB; Klimstra D; Cordon-Cardo C; Wong WD
Clin Cancer Res; 2002 Dec; 8(12):3841-9. PubMed ID: 12473598
[TBL] [Abstract][Full Text] [Related]
36. Detection of apoptotic cells and expression of Ki-67 antigen, Bcl-2, p53 oncoproteins in human parathyroid adenoma.
Wang W; Johansson H; Kvasnicka T; Farnebo LO; Grimelius L
APMIS; 1996 Nov; 104(11):789-96. PubMed ID: 8982242
[TBL] [Abstract][Full Text] [Related]
37. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
38. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
[TBL] [Abstract][Full Text] [Related]
39. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
40. Molecular profile of parathyroid tissues and tumours: a heterogeneous landscape.
Uljanovs R; Strumfa I; Bahs G; Vidusa L; Merkurjeva K; Franckevica I; Strumfs B
Pol J Pathol; 2021; 72(2):99-116. PubMed ID: 34706517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]